샘플 요청 목록

 카트 문의
시장보고서
상품코드
1559475

세계 수동 소생기 시장 : 인사이트, 경쟁 환경, 시장 예측(-2030년)

Manual Resuscitator - Market Insights, Competitive Landscape, and Market Forecast - 2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

수동 소생기 시장 규모는 2024-2030년의 예측 기간 동안 CAGR 6.13%로 성장할 것으로 예측됩니다.

수동 소생기 시장은 심정지 및 만성 폐색성 폐 질환(COPD)과 같은 심폐 및 호흡기 질환의 발생률 증가와 같은 몇 가지 주요 요인에 의해 견인되고 있습니다. 또한 병원 밖에서의 심정지, 외상, 사고 발생률의 높이도 긴급용 수동 소생기의 요구를 높여가고 있습니다. 또한 노년 인구 증가와 세계 제조업체의 수동 소생기 신제품 및 개량품의 지속적인 전개도 예측 기간 동안 시장 성장을 뒷받침하고 있습니다.

Resuscitation Council UK가 제공한 최신 데이터에 따르면, 2021년 원외심정지(OHCA)의 연간 발생률은 인구 10만명당 약 55명이었습니다. 심정지의 대부분(72%)은 가정에서 발생하고, 또 15%는 직장에서 발생하고 있습니다. 심정지의 대부분(98%)은 성인에서 발생하며, 그 3분의 1(33%)은 15-64세입니다. 원내 심정지(IHCA)의 연간 발생률은 입원 환자 1,000명당 1-1.5명입니다. IHCA를 일으킨 사람의 평균 연령은 70세이며, 1/4(26.7%)은 16-64세입니다. 이와 같이, 원외 및 원내에서의 심정지의 발생률이 상승하고 있기 때문에 수동 소생기의 중요한 필요성이 부각되고 있습니다. 의료 제공업체, 응급대원 및 공중보건기구는 생존율과 환자 결과를 개선하는 데 점점 더 중점을 두고 있으며, 고품질의 수동 소생기 수요를 견인하고 있습니다. 게다가 의식 증가와 즉각적인 대응 능력에 대한 중요한 요구는 직접 수동 소생기에 대한 수요의 급증으로 이어져 시장 성장과 소생 기술 혁신에 박차를 가하고 있습니다.

또한 WHO의 최신 데이터(2023년)에 따르면 COPD 환자 수는 세계에서 3억 9,200만 명으로 추정되고 있습니다. 또한 Australian Institute of Health and Welfare가 제공한 데이터(2023년)에 따르면 COPD는 2023년 호흡기 질환 부담의 50%, 전 질환 부담에서는 3.6%를 차지하고 있습니다. COPD는 세계의 이환율과 사망률의 주요 원인이며, 종종 심각한 호흡 곤란과 급성 악화를 일으키고 급한 호흡기 지원이 필요합니다. COPD 환자가 증가함에 따라 긴급 상황에서 효율적이고 신뢰할 수 있는 산소 공급이 가능한 수동 소생기 수요도 증가하여 시장 전체를 밀어 올리고 있습니다.

이 보고서는 세계 수동 소생기 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법 규제 환경, 시장 규모 추이 및 예측, 각종 구분, 지역/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.

목차

제1장 수동 소생기 시장 : 소개

제2장 수동 소생기 시장 : 주요 요약

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 수동 소생기 시장 : 주요 요인 분석

  • 시장 성장 촉진요인
    • COPD의 이환율 증가
    • 심폐정지 발생률 증가
    • 소생에 대한 의식 향상
  • 시장 성장 억제요인과 과제
    • 수동 소생기와 관련된 합병증
    • 긴급시 호흡 보조를 제공하는 대체 수단의 존재
  • 수동 소생기 시장 기회
    • 전기 임피던스 스토모그래피(EIT) 기술에 대한 지속적인 R&D 활동

제6장 수동 소생기 시장 : Porter's Five Forces 분석

제7장 수동 소생기 시장 : 시장 평가

  • 유형별
    • 자기팽창식
    • 유량팽창식
  • 용도별
    • 일회용
    • 재사용 가능
  • 환자별
    • 성인
    • 신생아
    • 소아
  • 용도별
    • 심폐폐색성 질환(COPD)
    • 심폐정지
    • 기타
  • 최종 사용자별
    • 병원 및 클리닉
    • 외래수술센터(ASC)
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 수동 소생기 시장 : 기업 및 제품 프로파일

  • Vyaire Medical Inc.
  • Ambu A/S
  • Teleflex Inc.
  • Zeal Medical Private Limited
  • Medline Industries Inc.
  • Allied Healthcare
  • GE Healthcare
  • Drager Medical AG and Co.
  • Laerdal Medical
  • Hopkins Medical Products
  • Mercury Medical
  • Cardinal Health
  • Bayer AG
  • McKesson Corporation
  • Romsons

제9장 KOL의 견해

제10장 프로젝트 접근

제11장 DelveInsight 정보

제12장 면책사항 및 문의

JHS 24.10.02

Manual Resuscitators Market by Type (Self-Inflating and Flow-Inflating), Usage (Disposable and Reusable), Patient (Adults, Neonatal, and Pediatric), Application (Cardiopulmonary Obstructive Disorders (COPD), Cardiac Pulmonary Arrest, and Others), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of cardiopulmonary obstructive disorders (COPD), increasing prevalence of cardiac pulmonary arrest, and increasing awareness about resuscitation across the globe.

The manual resuscitators market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030. The market for manual resuscitators is driven by several key factors. The increasing incidence of cardiopulmonary and respiratory conditions, such as cardiac arrest and chronic obstructive pulmonary disease (COPD). Additionally, the high incidence of out-of-hospital cardiac arrests, trauma, and accidents also drives the need for emergency manual resuscitators. Further, the growing geriatric population and continuous introduction of new and improved manual resuscitators by manufacturers worldwide are propelling market growth during the forecast period from 2024 to 2030.

Manual Resuscitators Market Dynamics

According to the latest data provided by the Resuscitation Council UK (2021), in 2021, the annual incidence of out-of-hospital cardiac arrest (OHCA) was approximately 55 per 100,000 inhabitants. Most cardiac arrests (72%) occur in the home, with an additional 15% occurring in the workplace. The vast majority of cardiac arrests (98%) occur in adults, with one-third (33%) of these adults aged 15-64 years. The annual incidence of in-hospital cardiac arrest (IHCA) is 1 to 1.5 per 1,000 hospital admissions. The average age of individuals sustaining an IHCA is 70 years, with a quarter (26.7%) aged 16-64 years. Thus, the rising incidence of both out-of-hospital and in-hospital cardiac arrests underscored the critical need for manual resuscitators. Healthcare providers, emergency responders, and public health organizations are increasingly focused on improving survival rates and patient outcomes, driving the demand for high-quality manual resuscitators. Additionally, the heightened awareness and the critical need for immediate response capabilities directly translate into a surge in demand for manual resuscitators, fueling market growth and innovation in resuscitation technologies.

Additionally, as per the latest data provided by the World Health Organization (2023), it was estimated that there were 392 million cases of COPD globally. Furthermore, as per the data provided by the Australian Institute of Health and Welfare (2023), COPD accounted for 3.6% of the total disease burden from 50% of the burden of respiratory conditions in 2023. COPD, a leading cause of morbidity and mortality worldwide, often leads to severe respiratory distress and acute exacerbations that require immediate respiratory support. As the number of COPD patients rises, so does the demand for manual resuscitators which are capable of providing efficient and reliable oxygen during emergencies thereby boosting the overall market.

Additionally, the market is expected to see a boost from the approval of newly developed resuscitators. For instance, in October 2022, Laerdal Medical announced that its NeoNatalie Resuscitator received approval under the new EU Medical Device Regulation (MDR). Thus, the increasing product approvals and new launches boost the market for manual resuscitators by expanding reach, increasing product visibility, optimizing distribution, offering targeted sales and support, and creating market differentiation and competitive advantages.

However, the complications associated with manual resuscitators and the presence of alternative methods that provide respiratory support in emergencies may result in slight obstacles to the growth of the manual resuscitators market.

Manual Resuscitators Market Segment Analysis:

Manual Resuscitators Market by Type (Self-Inflating and Flow-Inflating), Usage (Disposable and Reusable), Patient (Adults, Neonatal, and Pediatric), Application (Cardiopulmonary Obstructive Disorders (COPD), Cardiac Pulmonary Arrest, and Others), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the patient segment of the manual resuscitators market, the neonatal category is estimated to have a significant revenue share in the manual resuscitators market in 2023. The applications of neonatal resuscitators provide effective respiratory support tailored to the delicate needs of newborn infants. These resuscitators are designed to accommodate the unique physiology of newborns, including their smaller airways and respiratory requirements. Neonatal resuscitators are user-friendly and are often designed for ease of use in high-stress environments such as delivery rooms and NICUs. Neonatal resuscitators are boosting the overall resuscitator market more significantly due to the critical need for effective neonatal care. The specialized nature of these devices, coupled with increased awareness, regulatory support, and focused investments in neonatal healthcare infrastructure, drives their higher market demand and growth compared to other types of resuscitators.

Additionally, the rising number of preterm births, which often require respiratory support, further boosts the market for neonatal resuscitation devices. For instance, as per the latest data provided by the World Health Organization (2023), an estimated 13.4 million babies were born preterm in 2020. Furthermore, as per the data provided by the Pan America Health Organization (2023), of every 10 babies born, 1 is preterm and every 40 seconds, 1 of those babies dies across the world. The underdeveloped lungs of preterm infants are not fully equipped to handle the transition to breathing air outside the womb. As a result, many premature babies experience respiratory distress syndrome, thus the need for resuscitators in preterm infants is further increased thereby boosting the market of infant resuscitators and thus boosting the overall market of resuscitators.

Thus, due to the above-mentioned factors, the neonatal category is estimated to amass significant revenue, which will further in return boost the market for manual resuscitators during the forecast period.

North America Is Expected To Dominate The Overall Manual Resuscitators Market:

North America is expected to account for the highest proportion of the manual resuscitators market in 2023, out of all regions. The burgeoning market for manual resuscitators is underpinned by a complex interplay of factors, each contributing to its rapid expansion. Chronic obstructive pulmonary disease (COPD) and cardiac pulmonary arrest are significant health challenges that drive the demand for manual resuscitators in North America. COPD, affects millions of people in the region, leading to frequent exacerbations that require immediate respiratory support. Furthermore, the growing awareness and implementation of resuscitation education programs further enhances the market for manual resuscitators by emphasizing the importance of early intervention and proper resuscitation techniques.

According to recent data provided by the Heart and Stroke Statistics (2022), there were more than 356,000 out-of-hospital cardiac arrests (OHCA) annually in the U.S. The incidence of emergency medical services-assessed non-traumatic OHCA in people of any age is estimated to be 356,461, or nearly 1,000 people each day. Thus, the data serve as a compelling driver for the manual resuscitator market in the region. Healthcare providers, emergency responders, and public health organizations are increasingly recognizing the need for quick and effective intervention in cardiac arrest scenarios. This recognition is likely to spur investments in resuscitators that can enhance the chances of survival for cardiac arrest victims thereby boosting the market for manual resuscitators in the region.

As per the recent data provided by American Lung Association (2024) findings, approximately 1.7 million adults, constituting 4.6% of the adult population of the US, had reported a diagnosis of COPD, encompassing chronic bronchitis or emphysema. Notably, there was a higher prevalence of COPD among women than men, as well as among individuals aged 65 and older compared to younger age brackets. In conclusion, the rising prevalence of COPD in the US is anticipated to fuel the growth of the manual resuscitator market in the US, which will in return fuel the market growth for manual resuscitators in North America.

Thus, the above mentioned factors are expected to escalate the market of manual resuscitators in the region.

Manual Resuscitators Market Key Players:

Some of the key market players operating in the manual resuscitators market include Vyaire Medical Inc., Ambu A/S, Teleflex Inc., Zeal Medical Private Limited, Medline Industries Inc., Allied Healthcare, GE Healthcare, Drager Medical AG and Co., Laerdal Medical, Hopkins Medical Products, Mercury Medical, Cardinal Health, Bayer AG, McKesson Corporation, Romsons, and others.

Recent Developmental Activities In The Manual Resuscitators Market:

  • In October 2023, Mercury Medical donates Neo-Tee(R) T-Piece Resuscitators to Neonatologists in Africa.
  • In April 2022, South Bruce Grey Health Centre launched a new digital resuscitation education program in partnership with the American Heart Association and Laerdal Medical. Endorsed by the Heart and Stroke Foundation of Canada, the Resuscitation Quality Improvement (RQI) program offered training in Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and Paediatric Advanced Life Support (PALS).

Key Takeaways From The Manual Resuscitators Market Report Study

  • Market size analysis for current manual resuscitators size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the manual resuscitators market.
  • Various opportunities available for the other competitors in the manual resuscitators market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current manual resuscitators market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for manual resuscitators market growth in the coming future?

Target Audience Who Can Be Benefited From This Manual Resuscitators Market Report Study

  • Manual resuscitators product providers
  • Research organizations and consulting companies
  • Manual resuscitators -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in manual resuscitators
  • Various end-users who want to know more about the manual resuscitators market and the latest technological developments in the manual resuscitators market.

Frequently Asked Questions For The Manual Resuscitators Market:

1. What are manual resuscitators?

Manual resuscitators, also known as bag-valve-mask (BVM) devices or self-inflating bags, are essential medical devices used to provide positive pressure ventilation to patients who are not breathing adequately or are in respiratory distress. These devices are commonly used in emergency and critical care settings, including hospitals, ambulances, and clinics.

2. What is the market for manual resuscitators?

The manual resuscitators market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030.

3. What are the drivers for the manual resuscitators market?

The market for manual resuscitators is driven by several key factors. The increasing incidence of cardiopulmonary and respiratory conditions, such as cardiac arrest and chronic obstructive pulmonary disease (COPD). Additionally, the high incidence of out-of-hospital cardiac arrests, trauma, and accidents also drives the need for emergency manual resuscitators. Further, the growing geriatric population and continuous introduction of new and improved manual resuscitators by manufacturers worldwide are propelling market growth during the forecast period from 2024 to 2030.

4. Who are the key players operating in the manual resuscitators market?

Some of the key market players operating in the manual resuscitators are Vyaire Medical Inc., Ambu A/S, Teleflex Inc., Zeal Medical Private Limited, Medline Industries Inc., Allied Healthcare, GE Healthcare, Drager Medical AG and Co., Laerdal Medical, Hopkins Medical Products, Mercury Medical, Cardinal Health, Bayer AG, McKesson Corporation, Romsons, and others.

5. Which region has the highest share in the manual resuscitators market?

North America is expected to account for the highest proportion of the manual resuscitators market in 2023, out of all regions. The rising prevalence of chronic obstructive pulmonary disease (COPD) and cardiac pulmonary arrest is a major driver boosting the demand for manual resuscitators in North America. Furthermore, the growing awareness and implementation of resuscitation education programs enhance the market for manual resuscitators by emphasizing the importance of early intervention and proper resuscitation techniques.

Table of Contents

1. Manual Resuscitators Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Manual Resuscitators Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Manual Resuscitators Market Key Factors Analysis

  • 5.1. Manual Resuscitators Market Drivers
    • 5.1.1. Growing prevalence of cardiopulmonary obstructive disorders (COPD)
    • 5.1.2. Increasing prevalence of cardiac pulmonary arrest
    • 5.1.3. Increasing awareness about resuscitation across the globe.
  • 5.2. Manual Resuscitators Market Restraints and Challenges
    • 5.2.1. Complications associated with manual resuscitators
    • 5.2.2. The presence of alternative methods that provide respiratory support in emergencies
  • 5.3. Manual Resuscitators Market Opportunities
    • 5.3.1. Ongoing research & developmental activities on electrical impedance tomography (EIT) technique

6. Manual Resuscitators Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Manual Resuscitators Market Assessment

  • 7.1. By Type
    • 7.1.1. Self-Inflating
    • 7.1.2. Flow-Inflating
  • 7.2. By Usage
    • 7.2.1. Disposable
    • 7.2.2. Reusable
  • 7.3. By Patient
    • 7.3.1. Adults
    • 7.3.2. Neonatal
    • 7.3.3. Pediatric
  • 7.4. By Application
    • 7.4.1. Cardiopulmonary Obstructive Disorders (COPD)
    • 7.4.2. Cardiac Pulmonary Arrest
    • 7.4.3. Others
  • 7.5. By End-user
    • 7.5.1. Hospitals & Clinics
    • 7.5.2. Ambulatory Surgical Centers
    • 7.5.3. Others
  • 7.6. By Geography
    • 7.6.1. North America
      • 7.6.1.1. United States Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.1.2. Canada Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.1.3. Mexico Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.2. Europe
      • 7.6.2.1. France Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.2.2. Germany Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.2.3. United Kingdom Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.2.4. Italy Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.2.5. Spain Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.2.6. Rest of Europe Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.3. Asia-Pacific
      • 7.6.3.1. China Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.3.2. Japan Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.3.3. India Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.3.4. Australia Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.3.5. South Korea Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.3.6. Rest of Asia-Pacific Manual Resuscitators Market Size in USD Million (2021-2030)
    • 7.6.4. Rest of the World (RoW)
      • 7.6.4.1. Middle East Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.4.2. Africa Manual Resuscitators Market Size in USD Million (2021-2030)
      • 7.6.4.3. South America Manual Resuscitators Market Size in USD Million (2021-2030)

8. Manual Resuscitators Market Company and Product Profiles

  • 8.1. Vyaire Medical Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Ambu A/S
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Teleflex Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Zeal Medical Private Limited
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Medline Industries Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Allied Healthcare
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. GE Healthcare
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Drager Medical AG and Co.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Laerdal Medical
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Hopkins Medical Products
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Mercury Medical
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Cardinal Health
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Bayer AG
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. McKesson Corporation
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Romsons
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제